IL165172A0 - Compositions and method for enhanced mucosal delivery of interfern beta - Google Patents

Compositions and method for enhanced mucosal delivery of interfern beta

Info

Publication number
IL165172A0
IL165172A0 IL16517204A IL16517204A IL165172A0 IL 165172 A0 IL165172 A0 IL 165172A0 IL 16517204 A IL16517204 A IL 16517204A IL 16517204 A IL16517204 A IL 16517204A IL 165172 A0 IL165172 A0 IL 165172A0
Authority
IL
Israel
Prior art keywords
interfern
beta
compositions
mucosal delivery
enhanced mucosal
Prior art date
Application number
IL16517204A
Other languages
English (en)
Original Assignee
Nastech Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nastech Pharm Co filed Critical Nastech Pharm Co
Publication of IL165172A0 publication Critical patent/IL165172A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16517204A 2002-06-28 2004-11-11 Compositions and method for enhanced mucosal delivery of interfern beta IL165172A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39306602P 2002-06-28 2002-06-28
PCT/US2003/019261 WO2004002404A2 (fr) 2002-06-28 2003-06-18 Compositions et methodes destinees a une administration par voie muqueuse amelioree de l'interferon beta

Publications (1)

Publication Number Publication Date
IL165172A0 true IL165172A0 (en) 2005-12-18

Family

ID=30000968

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16517204A IL165172A0 (en) 2002-06-28 2004-11-11 Compositions and method for enhanced mucosal delivery of interfern beta

Country Status (8)

Country Link
US (2) US20040037809A1 (fr)
EP (1) EP1539220A4 (fr)
AU (1) AU2003267965A1 (fr)
CA (1) CA2486531A1 (fr)
IL (1) IL165172A0 (fr)
NZ (1) NZ536939A (fr)
WO (1) WO2004002404A2 (fr)
ZA (1) ZA200409652B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020141970A1 (en) * 2001-03-05 2002-10-03 Pettit Dean K. Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
US20040254146A1 (en) * 2002-05-21 2004-12-16 Nastech Pharmaceutical Company Inc. Carboxylate salts of galantamine and their pharmaceutical use
JP2005537244A (ja) * 2002-06-28 2005-12-08 ナステック・ファーマシューティカル・カンパニー・インコーポレーテッド 療法化合物の粘膜搬送を増進させるための、上皮接合部接着分子の生理機能を調節する組成物および方法
PL1708690T3 (pl) 2003-11-17 2017-01-31 Biomarin Pharmaceutical Inc. Leczenie fenyloketonurii za pomocą BH4
GB0405634D0 (en) * 2004-03-12 2004-04-21 Univ Southampton Anti-virus therapy for respiratory diseases
ZA200609412B (en) * 2004-05-17 2008-07-30 Ares Trading Sa Hydrogel interferon formulations
JP4988562B2 (ja) 2004-06-01 2012-08-01 アレス トレーディング ソシエテ アノニム 安定化したインターフェロン液体製剤
CN1984674A (zh) * 2004-06-07 2007-06-20 纳斯泰克制药公司 不含蛋白质或多肽类稳定剂的干扰素β鼻内制剂
CA2578709C (fr) * 2004-06-17 2010-06-15 Virun, Inc. Compositions comprenant une proteine adherant aux muqueuses et principe actif pour la delivrance d'agents dans des muqueuses
WO2006052773A2 (fr) * 2004-11-07 2006-05-18 Androclus Therapeutics Inc. Traitement pour des affections demyelinisantes a mediation immunitaire
WO2007029238A2 (fr) * 2005-09-06 2007-03-15 Oramed Pharmaceuticals, Inc. Procedes et compositions pour l'administration orale de proteines
CA2622016A1 (fr) * 2005-09-09 2007-03-15 Imperial Innovations Limited Therapie par interferon lambda pour le traitement de maladies respiratoires
PT2236608T (pt) 2005-10-04 2017-03-01 Soligenix Inc Péptidos novos para tratar e prevenir distúrbios relacionados com a imunidade, incluindo tratar e prevenir infecção por modulação da imunidade inata
EP1948201A4 (fr) 2005-11-14 2013-12-25 Valorisation Recherche Ltd Partnership Compositions pharmaceutiques comprenant des liants polymères à liaisons covalentes non hydrolysables et leur utilisation pour le traitement de la maladie coeliaque
GB0602980D0 (en) 2006-02-14 2006-03-29 Optinose As Delivery device and method
US9023793B2 (en) * 2006-09-29 2015-05-05 Retrophin, Inc. Intranasal carbetocin formulations and methods for the treatment of autism
SG175573A1 (en) * 2006-10-04 2011-11-28 Inimex Pharmaceuticals Inc Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
JP5563475B2 (ja) 2007-12-20 2014-07-30 メルク セローノ ソシエテ アノニム Ｐｅｇインターフェロン−ベータ製剤
US8062663B2 (en) * 2008-05-23 2011-11-22 National Health Research Instittues Methods and compostions for enhancing transdermal drug delivery
EP2742057B1 (fr) * 2011-08-12 2016-04-20 The Board of Trustees of The Leland Stanford Junior University Compositions et procédés pour la régulation spécifique de la pyruvate déshydrogénase kinase
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
RU2482872C1 (ru) * 2012-04-02 2013-05-27 Илья Александрович Марков Фармацевтическая композиция в форме капсулы, обладающая противовирусным, противовоспалительным, антимикробным и иммуномодулирующим действием
KR102320059B1 (ko) 2012-06-13 2021-11-01 아스트라제네카 아베 항-i형 인터페론 수용체(ifnar) 항체에 대한 고정 투여 계획
JP6363022B2 (ja) * 2013-01-28 2018-07-25 国立研究開発法人産業技術総合研究所 抗体結合性ペプチド
ES2920802T3 (es) * 2013-03-26 2022-08-09 Optinose As Administración nasal
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
CN105496635A (zh) * 2016-01-21 2016-04-20 江苏得迪医疗器械有限公司 一种保水缓释退热贴及其制备方法
JP6818305B2 (ja) 2016-09-01 2021-01-20 国立研究開発法人産業技術総合研究所 非天然型立体構造を形成した抗体に親和性を示すポリペプチド
TWI856084B (zh) * 2019-04-01 2024-09-21 美商建南德克公司 用於穩定含有蛋白質之配方之組合物及方法
KR102192471B1 (ko) * 2019-10-18 2020-12-17 주식회사 인코스팜 탈모 완화 및 모발 성장을 촉진시키는 펩타이드 및 이를 포함하는 화장료 조성물
CN120392997A (zh) 2021-04-23 2025-08-01 阿斯利康(瑞典)有限公司 用于皮下注射的抗ifnar1给药方案
WO2023101616A1 (fr) * 2021-12-03 2023-06-08 Silpakorn University Composition et procédé de fabrication d'une solution de pulvérisation nasale pour le traitement et la prévention de covid-19
CN114924088B (zh) * 2022-05-09 2023-09-26 安徽伊普诺康生物技术股份有限公司 一种强抗干扰且稳定的afu检测试剂盒及其制备方法
WO2024159015A1 (fr) * 2023-01-25 2024-08-02 North Carolina State University Compositions et méthodes se rapportant à des compositions thérapeutiques inhalables

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005535A1 (fr) * 1988-11-14 1990-05-31 Otsuka Pharmaceutical Co., Ltd. Preparation a base d'interferon pour administration nasale
US5906816A (en) * 1995-03-16 1999-05-25 University Of Florida Method for treatment of autoimmune diseases
US5273965A (en) * 1992-07-02 1993-12-28 Cambridge Biotech Corporation Methods for enhancing drug delivery with modified saponins
US5840770A (en) * 1993-08-24 1998-11-24 Hill Medical Corporation Method of killing tumor cells
JPH0912467A (ja) * 1995-04-28 1997-01-14 Teijin Ltd 経粘膜投与用α２マクログロブリン族包接複合体
RU2140285C1 (ru) * 1999-01-25 1999-10-27 Гапонюк Петр Яковлевич Противовирусное средство - капли в нос "гриппферон"
WO2001041782A2 (fr) * 1999-12-09 2001-06-14 Chiron Corporation Procede d'administration de cytokine aux systeme nerveux central et systeme lymphatique
US6465425B1 (en) * 2000-02-10 2002-10-15 Alkermes Controlled Therapeutics, Inc. Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
US6887462B2 (en) * 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
US20030138403A1 (en) * 2001-06-29 2003-07-24 Maxygen Aps Interferon formulations

Also Published As

Publication number Publication date
EP1539220A4 (fr) 2008-04-02
US20080113011A1 (en) 2008-05-15
AU2003267965A1 (en) 2004-01-19
US20040037809A1 (en) 2004-02-26
WO2004002404A2 (fr) 2004-01-08
NZ536939A (en) 2006-07-28
CA2486531A1 (fr) 2004-01-08
WO2004002404A3 (fr) 2004-06-17
EP1539220A2 (fr) 2005-06-15
ZA200409652B (en) 2006-07-26

Similar Documents

Publication Publication Date Title
IL165172A0 (en) Compositions and method for enhanced mucosal delivery of interfern beta
IL144325A0 (en) Compositions and methods for mucosal delivery
AU2003279010A8 (en) Compositions and methods for delivery of short interfering rna and short hairpin rna
SI1585548T1 (sl) Sestave in metode odmerjanja farmakoloških sredstev
AU2003284115A8 (en) Method of delivering local anesthesia
PT2314171T (pt) Composições e processo para entregar um aditivo
AU2003219942A8 (en) Composition and process for well cleaning
EP1572262A3 (fr) Procede d'administration d'une anesthesie locale
ZA200409126B (en) Composition for solubilization of paclitaxel and preparation method thereof
AU2003284387A1 (en) Delivery composition and method
AU2003287443A8 (en) Compositions and methods for pain reduction
GB0303609D0 (en) Novel therapeutic method and compositions
EP1333825A4 (fr) Technique d'apport d'oxybutynine ameliore et compositions de cette derniere
EP1542609B8 (fr) Compositions comprenant l'Interféron bêta pour leur utilisation dans le traitement du mélanome
EP1569973A4 (fr) Composition de microgel et procede de preparation associe
IL163981A0 (en) Androgen pharmaceutical composition and method fortreating depression
EP1633328A4 (fr) Procede et composition d'administration stable et controlee d'acide (-)-hydroxycitrique
ZA200600025B (en) Methods and compositions for interferon therapy
AU2003295574A8 (en) Method and compositions for temporarily incapaciting subjets
AU2003210474A8 (en) Composition and method for inhibiting hypersensitivity
AU2002330801A1 (en) Method for oral transmucosal delivery of interferon
GB0303600D0 (en) Novel therapeutic method and compositions
ZA200505380B (en) Compositions and methods of delivery of pharmacological agents
GB0203528D0 (en) Process and composition
AU2002364714A8 (en) Method for electronic delivery of advertisements